⏳
Showing Q3 2024 data
Bill & Melinda Gates Foundation's Q4 2025 filing not yet available. Expected by Feb 14, 2026.
Bill & Melinda Gates Foundation
•CIK: 1663801•Filing: Q3 2024
**Bill & Melinda Gates Foundation** A $44M portfolio managing five distinct positions, exhibiting a focused, impact-oriented investment strategy. The fund's largest allocation is to BNTX at $17.7M, followed by a significant holding in VIR at $11.7M. Further diversification includes notable stakes in VYLD ($7.8M), RJF ($4.6M), and BFLY ($1.8M). This structure suggests targeted capital deployment toward specific sectors aligned with philanthropic objectives.
Total AUM
$43.5M
QoQ Performance
-27.2%
Positions
5
Top 10 Concentration
100.0%
Latest Filing
Q3 2024
Top Holdings Allocation
BNTX
VIR
EXSC
CURE
BNTX40.6%
VIR26.8%
EXSCIENTIA17.8%
CUREVAC10.6%
BFLY4.1%
📈 Biggest Buys
No new positions or increases this quarter
📉 Biggest Sells
—
CUREVAC N V
-1.8%
10.6% of portfolio
Sector Breakdown
Other100.0%
🚪 Exited Positionssold since Q2 2024
Changes from Q2 2024
↓1 decreased
Historical Filings
Q3 2024Q2 2024Q1 2024Q4 2023